Antonella Ferro
Trento, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 66 publications
Challenging the cornerstone: Toward risk-adapted follow-up in early breast cancer.
Journal: Tumori
Published: June 30, 2026
Prognostic value of post-neoadjuvant pathological response and residual disease in early breast cancer: a real-world cohort study.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: June 02, 2026
Second-line therapies after CDK4/6 inhibitor failure in HR-positive/HER2-negative metastatic breast cancer patients: real-world data from the HERMIONE-13 study.
Journal: ESMO real world data and digital oncology
Published: April 03, 2026
Tumor infiltrating lymphocytes as a predictor of adjuvant avelumab efficacy in patients with high-risk triple negative breast cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 11, 2026
Postmastectomy radiation therapy in patients with human epidermal growth factor receptor 2 (HER2)-positive breast cancer: a retrospective exploratory cohort analysis of the adjuvant lapatinib and/or trastuzumab treatment optimization (ALTTO) trial [BIG 2-06/NCCTG N063D (Alliance)].
Journal: EClinicalMedicine
Published: February 09, 2026
DonnaRosa Project: Exploring Informal Communication Practices Among Breast Cancer Specialists.
Journal: Current oncology (Toronto, Ont.)
Published: November 05, 2025
A-BRAVE trial: a phase III randomized trial with anti-PD-L1 avelumab in high-risk triple-negative early breast cancer patients.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: May 13, 2025
TreC_Metha: A Digital Application to Enhance Patient Agency, Therapy Compliance and Quality of Life in Metastatic Breast Cancer Patients.
Journal: Current oncology (Toronto, Ont.)
Published: March 20, 2025
Tumor-Infiltrating Lymphocytes and Survival Outcomes in Early ERBB2-Positive Breast Cancer: 10-Year Analysis of the ShortHER Randomized Clinical Trial.
Journal: JAMA oncology
Published: February 13, 2025
Chatbot-Based Version of a World Health Organization-Validated Intervention for Stress Management in Patients With Breast Cancer (Self-Help Plus): Protocol for a Pilot Feasibility Study.
Journal: JMIR research protocols
Published: August 28, 2024
Last Updated: 09/26/2026